Top Five Radiology Content — March 2025

News
Slideshow

Catch up on the most-well viewed radiology content in March 2025.

Touching on a variety of topics in radiology, ranging from photon-counting computed tomography (PCCT) for assessing liver fat fraction and the use of generative AI to reduce chest X-ray reading to a new podcast on appropriate use criteria for brain positron emission tomography (PET), here are the top five most well-viewed content for March 2025.

Recent Videos
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
Related Content
Nine Takeaways from New Research on CT Scans and Radiation-Induced Cancers

Nine Takeaways from New Research on CT Scans and Radiation-Induced Cancers

Jeff Hall
April 18th 2025
Article

Recently published research projected that 103,000 future cases of radiation-induced cancer would result from 93 million computed tomography (CT) exams performed in the United States in 2023.

The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET

The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET

Jeff Hall
March 18th 2025
Podcast

In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.

FDA Clears Emerging Digital Tomosynthesis System

FDA Clears Emerging Digital Tomosynthesis System

Jeff Hall
April 17th 2025
Article

The Nanox.ARC X system reportedly provides enhanced 3D imaging for a variety of indications, ranging from pulmonary imaging and intra-abdominal views to musculoskeletal assessment.

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 3

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 3

Jeff Hall
September 1st 2023
Podcast

In the third episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss the challenges of expanded breast cancer screening amid a backdrop of radiologist shortages and ever-increasing volume on radiology worklists.

FDA Expands Clearance for AI Mammography Software for Breast Arterial Calcification Detection

FDA Expands Clearance for AI Mammography Software for Breast Arterial Calcification Detection

Jeff Hall
April 16th 2025
Article

The additional FDA 510(k) clearance for the AI-powered cmAngio platform covers use of the software for GE HealthCare mammography systems.

Breast MRI Quantification of Intra-Tumoral Heterogeneity May Help Predict Response to Neoadjuvant Chemotherapy

Breast MRI Quantification of Intra-Tumoral Heterogeneity May Help Predict Response to Neoadjuvant Chemotherapy

Jeff Hall
April 16th 2025
Article

An emerging nomogram model for intra-tumoral heterogeneity quantification with breast MRI demonstrated an average 85 percent sensitivity in external validation testing for predicting pathologic complete response to neoadjuvant chemotherapy for breast cancer.

© 2025 MJH Life Sciences

All rights reserved.